|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||675.75||71.55||159,483.80||327.39||1.13||3,119.04||104.36|
|Divis Laboratories Ltd||4,281.10||57.72||112,813.53||487.93||0.47||1,718.39||349.25|
|Dr Reddys Laboratories Ltd||5,309.00||40.16||87,807.45||311.50||0.47||3,313.50||1,020.99|
|Cadila Healthcare Ltd||625.70||38.80||63,236.58||464.70||0.57||1,949.70||124.49|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Saamya Bio-tech (India) Ltd was incorporated as a Public Limited Company on August 13, 2002. With the primary objective to carry on the business of manufacture, buy, import, export and generally deal in all types of chemicals, pharmaceuticals, drugs and intermediates. Presently, the Company is not undertaking any activity.The Company has proposes to set up manufacturing facility in Shapoorji Pallonji Biotech Park Pvt Ltd, at Kolthur vi... More